MARCY WILLIAMSON: Open Payments
NPI 1366183923 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,964 in 171 payments from 47 companies in 2025. Trend: 2023 $2,845 · 2024 $3,504 · 2025 $3,964
Food & beverage: $3,886Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $324 |
| E.R. Squibb & Sons, L.L.C. | 17 | $293 |
| Janssen Biotech, Inc. | 9 | $219 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| Daiichi Sankyo Inc. | 8 | $197 |
| Regeneron Healthcare Solutions, Inc. | 5 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $156 |
| Gilead Sciences, Inc. | 4 | $154 |
| Astellas Pharma US Inc | 6 | $137 |
| Celgene Corporation | 6 | $136 |
Products named: OPDIVO, Nubeqa, Trodelvy, Enhertu, VENCLEXTA, LIBTAYO, KEYTRUDA, Fabhalta.
Industry payments across TN — which companies pay providers there.
